.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Cipla
QuintilesIMS
Mallinckrodt
McKesson
Novartis
McKinsey
Express Scripts
Accenture

Generated: June 25, 2017

DrugPatentWatch Database Preview

Remifentanil hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for remifentanil hydrochloride and what is the scope of remifentanil hydrochloride freedom to operate?

Remifentanil hydrochloride
is the generic ingredient in one branded drug marketed by Mylan Institutional and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for remifentanil hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: remifentanil hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list10
Clinical Trials: see list2,632
Patent Applications: see list345
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:remifentanil hydrochloride at DailyMed

Pharmacology for Ingredient: remifentanil hydrochloride

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-002Jul 12, 1996RXYesNo5,866,591*PED► SubscribeY► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-003Jul 12, 1996RXYesYes5,866,591*PED► SubscribeY► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-001Jul 12, 1996RXYesNo5,866,591*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: remifentanil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-002Jul 12, 19965,466,700*PED► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-003Jul 12, 19965,466,700*PED► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-001Jul 12, 19965,019,583*PED► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-003Jul 12, 19965,019,583*PED► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-002Jul 12, 19965,019,583*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Deloitte
McKinsey
US Army
McKesson
Johnson and Johnson
Fuji
Merck
Cerilliant
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot